Transcript: Pfizer CEO Albert Bourla on “Face the Nation”

The following is a transcript of an interview with Pfizer CEO Dr. Albert Bourla that aired Sunday, September 13, 2020, on “Face the Nation.”

MARGARET BRENNAN: One of the companies hard at work on developing a vaccine for COVID-19 is Pfizer, and CEO Albert Bourla joins us now from Westchester, New York. Good morning to you.


MARGARET BRENNAN: Do you still expect to know by next month if your vaccine is effective?

DR. BOURLA: Yes, in our base case, we have quite the good- it’s more than  60% that we will know if the product works or not by the end of October. But of course that doesn’t mean that it works. It means that we will know if it works.

MARGARET BRENNAN: And then the time clock starts on government approval, which is a key factor there. I want to ask you about an announcement from Pfizer yesterday, which was that you’re going to expand your vaccine trial to increase diversity. You’re going to go from 30,000 people up to 44,000. What do you mean by diversity and what does it do for you?

DR. BOURLA: Yes, this study has recruited

View Source